People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Healthtech, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Roman Health Ventures Inc. | — | Healthtech | Growth/Late | $626.8M | $11.6B | 2020 |
| Color Health, Inc. | — | Biotechnology | Series D+ | $300.9M | $1.2B | 2016 |
| Humedica, Inc. | — | Other | Series B | $76.0M | $548.3M | 2011 |
Taneja Hemant at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Taneja Hemant on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hemant Taneja | 1 | 21 |
| Rick Heitzmann | 1 | 11 |
| James Nahirny | 1 | 4 |
| Paul Bleicher | 1 | 4 |
| Alexis Ohanian | 1 | 4 |
| William Geary | 1 | 3 |
| Michael Weintraub | 1 | 3 |
| Kenneth Novack | 1 | 3 |
| Othman Laraki | 1 | 2 |
| Saman Rahmanian | 1 | 2 |
| Elad Gil | 1 | 2 |
| Tony West | 1 | 2 |
| Rob Schutz | 1 | 2 |
| Susan L. Wagner | 1 | 1 |
| Michael L. Herring | 1 | 1 |
| Hemant L. Taneja | 1 | 1 |
| Gil Elad | 1 | 1 |
| Sherwin L Chen | 1 | 1 |
| ZACHARIAH REITANO | 1 | 1 |
| HAMANT TANEJA | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.